These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1359345)

  • 1. Spurious outbreak of HCV in bone-marrow recipients treated with cytomegalovirus immunoglobulin.
    Ward KN; Morgan G; Ashworth K; Bremner J; O'Callaghan A; Teo CG
    Lancet; 1992 Nov; 340(8830):1290-1. PubMed ID: 1359345
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to hepatitis C virus in human immunoglobulins: clinical meaning and diagnostic difficulties in children undergoing bone marrow transplant.
    Mateos ML; Camarero C; Maldonado S; Lasa E; Otheo E; Muñoz A
    Bone Marrow Transplant; 1994 Jul; 14(1):95-7. PubMed ID: 7524908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    JAMA; 1994 Aug; 272(6):424-5. PubMed ID: 8040966
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C virus antibody seroconversion in bone marrow transplant recipients treated with immune globulin: the impact of the problem.
    Lopez-Jimenez J; Villalon L; Mateos ML; Odriozola J
    Blood; 1994 Jul; 84(2):665-6. PubMed ID: 7517725
    [No Abstract]   [Full Text] [Related]  

  • 5. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C and immune globulin.
    López-Jiménez J; Odriozola J; Pérez-Oteyza J; García-Laraña J
    N Engl J Med; 1995 May; 332(18):1235-6. PubMed ID: 7700324
    [No Abstract]   [Full Text] [Related]  

  • 7. Do antibodies to the hepatitis G virus E2 antigen in immunoglobulin products reduce infectivity?
    Cristiano K; Bisso G; Wirz M; Gentili G
    Transfusion; 1999; 39(11-12):1271-2. PubMed ID: 10604257
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
    Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
    Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus transmission by intravenous immunoglobulin.
    Farrugia A; Walker E
    Lancet; 1995 Aug; 346(8971):373; author reply 374-5. PubMed ID: 7542718
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus transmission by intravenous immunoglobulin.
    James RC; Mosley JW
    Lancet; 1995 Aug; 346(8971):374; author reply 374-5. PubMed ID: 7542719
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of anti-HCV-reactive immunoglobulin in heart transplant patients.
    Donegani E; di Summa M; Bobbio M; Ghisetti V; Marchiaro G; Rizzetto M; Bonino F
    Lancet; 1992 Oct; 340(8826):1039. PubMed ID: 1383660
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C transmission associated with intravenous immunoglobulins.
    Nübling CM; Willkommen H; Löwer J
    Lancet; 1995 May; 345(8958):1174. PubMed ID: 7536875
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C infection in BMT patients.
    Kolho E; Ruutu P; Ruutu T
    Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin.
    Horst HA; Schmitz N; Glinike C; Löffler H; Laufs R
    N Engl J Med; 1991 Jul; 325(2):132-3. PubMed ID: 1646961
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party.
    Locasciulli A; Alberti A; de Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Reusser P; Ribaud P; Ljungman P
    Bone Marrow Transplant; 1994 Nov; 14(5):833-7. PubMed ID: 7534164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection and liver disease after allogeneic bone marrow transplantation.
    Fujii Y; Kaku K; Tanaka M; Kaneko T; Matumoto N; Shinohara K
    Bone Marrow Transplant; 1994 May; 13(5):523-6. PubMed ID: 7519934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up.
    Christie JM; Healey CJ; Watson J; Wong VS; Duddridge M; Snowden N; Rosenberg WM; Fleming KA; Chapel H; Chapman RW
    Clin Exp Immunol; 1997 Oct; 110(1):4-8. PubMed ID: 9353141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus core antigen for screening organ donors and recipients.
    Benito R; Arribas J; Algarate S; Cebollada R; Gude MJ
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):126-129. PubMed ID: 29477273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.